| Issue Date | Title | Author(s) |
| 2015 | Correction of adma-induced preeclampsia with the use of phosphodiesterase 5 and selective inhibitor of arginase II ZB49-0010 | Gureev, V. V.; Martynova, O. V.; Anciferova, O. E.; Martynov, M. A.; Pokrovskaia, T. G. |
| 2020 | Eleven-amino acid peptides that mimic the erythropoietin α-helix B increases cell survival in endotheliocyte culture | Antsiferov, O. V.; Korokin, M. V.; Gureev, V. V.; Pokrovskii, M. V.; Korokina, L. V.; Gudyrev, O. S.; Pokrovskaia, T. G. |
| 2015 | Endothelio- and cardioprotective effects of HMG-CoA reductase inhibitors under the condition of endotoxin-induced endothelial dysfunction | Denisuk, T. A.; Pokrovskii, M. V.; Philippova, O. V.; Dolzhikov, A. A.; Pokrovskaia, T. G.; Korokin, M. V.; Gudyrev, O. S. |
| 2019 | Integrated evaluation of the endothelioprotective activity of an innovative peptide simulating the alpha-helix of B-erythropoethin in L-name-induced nitrogen oxide deficiency at the late gestation period | Pokrovskii, M. V.; Yurakova, A. V.; Gureev, V. V.; Golubev, I. V.; Lokteva, T. I.; Korokin, M. V.; Gudyrev, O. S.; Pokrovskaia, T. G. |
| 2022 | Management of chronic obstructive pulmonary disease | Bontsevich, R. A.; Adonina, A. V.; Vovk, Y. R.; Batisheva, G. A.; Pokrovskaia, T. G. |
| 2019 | Study of the selective phenolic inhibitors of arginase 2 acute toxicity | Korokina, L. V.; Pokrovskii, M. V.; Korokin, M. V.; Pokopejko, O. N.; Pokrovskaia, T. G.; Galenko-Yaroshevsky, P. G.; Dolzhikov, A. A.; Reznichenko, L. V.; Yakovleva, E. G. |
| 2020 | The anti-aggregation activity of new 11-amino acid of erythropoietin derivate containing tripeptide motifs | Golubev, I. V.; Gureev, V. V.; Korokina, L. V.; Gudyrev, O. S.; Pokrovskaia, T. G.; Pokopeiko, O. N. |
